We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock
SILK

Delisted

SILK was delisted on the 16th of September, 2024.

Back to rankings

1 hedge funds and large institutions have $27 invested in Silk Road Medical, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 172 → 1 (-171)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $1.03B → $27 (-$1.03B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-171
Holders Change %
-99.42%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
170
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$91.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$80.3M
3
MF
Magnetar Financial
Illinois
-$53.3M
4
Fidelity International
Fidelity International
Bermuda
-$42.7M
5
BAMCO Inc
BAMCO Inc
New York
-$34.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
– -$13.1M -485,500 Closed
Bank of America
27
Bank of America
North Carolina
– -$12M -442,695 Closed
Marshall Wace
28
Marshall Wace
United Kingdom
– -$11.9M -440,254 Closed
WCMNY
29
Westchester Capital Management (New York)
New York
– -$11.8M -437,118 Closed
WIC
30
Water Island Capital
New York
– -$11M -406,305 Closed
TAL
31
TIG Advisors LLC
New York
– -$10.7M -396,245 Closed
SSA
32
Schonfeld Strategic Advisors
New York
– -$10.7M -394,476 Closed
Northern Trust
33
Northern Trust
Illinois
– -$9.02M -333,425 Closed
GF
34
Gabelli Funds
New York
– -$8.93M -330,423 Closed
Charles Schwab
35
Charles Schwab
California
– -$8.62M -318,638 Closed
Morgan Stanley
36
Morgan Stanley
New York
– -$8.46M -312,804 Closed
SC
37
Slotnik Capital
Texas
– -$8.11M -300,000 Closed
WP
38
Woodline Partners
California
– -$7.73M -286,016 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$7.73M -285,886 Closed
WA
40
Wasatch Advisors
Utah
– -$7.1M -262,654 Closed
GI
41
GAMCO Investors
Connecticut
– -$6.89M -254,750 Closed
Invesco
42
Invesco
Georgia
– -$6.42M -237,294 Closed
KC
43
Kryger Capital
United Kingdom
– -$5.74M -212,456 Closed
Goldman Sachs
44
Goldman Sachs
New York
– -$5.63M -208,028 Closed
Canada Pension Plan Investment Board
45
Canada Pension Plan Investment Board
Ontario, Canada
– -$5.62M -208,000 Closed
First Eagle Investment Management
46
First Eagle Investment Management
New York
– -$5.58M -206,220 Closed
HM
47
Harvest Management
New York
– -$5.3M -195,910 Closed
CCM
48
Chicago Capital Management
Illinois
– -$5.29M -195,504 Closed
OAC
49
OMERS Administration Corp
Ontario, Canada
– -$5.18M -191,500 Closed
TI
50
Trexquant Investment
Connecticut
– -$5.1M -188,668 Closed
1
2
3 4 5

SILK Hedge Fund Activity: Q3 2024 in Review

1 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2024, worth a combined $27 — down 100% from $1.03B a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of SILK and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $91.1M sold.

  • 1 institutional investor held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2024, down from 172 in Q2 2024.
  • Funds reported $27 of Silk Road Medical, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2024 and 170 closed out, a net change of -170 holders.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q3 2024 was BlackRock, an estimated $91.1M sold.

Based on aggregated 13F filings for Q3 2024.